News over the weekend that Jack Ma will relinquish control of Ant Group spurred gains for parent company Alibaba, which climbed 4% in premarket trade. Flying higher are three biopharmas — Cincor Pharma, Amryt Pharma and Albireo Pharma — [after deals to get acquired for hefty premiums](https://www
Source
Alibaba leads China ADR advance
